India should review its regulation of new therapeutic paths enabled by tech advances. Think of AI and the wonders of Crispr gene editing. Safe ways exist to test modern therapies in a country that’s well placed to make breakthroughs.

See all 38 in Opinion →

By

Leave a Reply

Your email address will not be published. Required fields are marked *